
David Guzo
Examiner (ID: 2124)
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1805, 1636, 2899 |
| Total Applications | 1205 |
| Issued Applications | 693 |
| Pending Applications | 160 |
| Abandoned Applications | 352 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5844151
[patent_doc_number] => 20020132236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Specific inhibitors of ribosome recycling factors (RRF)'
[patent_app_type] => new
[patent_app_number] => 09/824304
[patent_app_country] => US
[patent_app_date] => 2001-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4846
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132236.pdf
[firstpage_image] =>[orig_patent_app_number] => 09824304
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/824304 | Specific inhibitors of ribosome recycling factors (RRF) | Apr 1, 2001 | Abandoned |
Array
(
[id] => 6080689
[patent_doc_number] => 20020081680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Compositions and methods for the therapy and diagnosis of prostate cancer'
[patent_app_type] => new
[patent_app_number] => 09/822827
[patent_app_country] => US
[patent_app_date] => 2001-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 75080
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20020081680.pdf
[firstpage_image] =>[orig_patent_app_number] => 09822827
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/822827 | Compositions and methods for the therapy and diagnosis of prostate cancer | Mar 27, 2001 | Abandoned |
Array
(
[id] => 6864803
[patent_doc_number] => 20030190329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Coxsackievirus vectors and their use in prevention and treatment of disease'
[patent_app_type] => new
[patent_app_number] => 09/817748
[patent_app_country] => US
[patent_app_date] => 2001-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14446
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20030190329.pdf
[firstpage_image] =>[orig_patent_app_number] => 09817748
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/817748 | Coxsackievirus vectors and their use in prevention and treatment of disease | Mar 25, 2001 | Abandoned |
Array
(
[id] => 6739761
[patent_doc_number] => 20030157130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Modified nodavirus rna for gene delivery'
[patent_app_type] => new
[patent_app_number] => 10/221993
[patent_app_country] => US
[patent_app_date] => 2003-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 8402
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157130.pdf
[firstpage_image] =>[orig_patent_app_number] => 10221993
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/221993 | Modified nodavirus RNA for gene delivery | Mar 25, 2001 | Issued |
Array
(
[id] => 6884882
[patent_doc_number] => 20010039044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-08
[patent_title] => 'Helper virus-free AAV production'
[patent_app_type] => new
[patent_app_number] => 09/813041
[patent_app_country] => US
[patent_app_date] => 2001-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6160
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20010039044.pdf
[firstpage_image] =>[orig_patent_app_number] => 09813041
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/813041 | Helper virus-free AAV production | Mar 20, 2001 | Issued |
Array
(
[id] => 1589790
[patent_doc_number] => 06482919
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-11-19
[patent_title] => 'Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell'
[patent_app_type] => B2
[patent_app_number] => 09/813659
[patent_app_country] => US
[patent_app_date] => 2001-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 23
[patent_no_of_words] => 18070
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/482/06482919.pdf
[firstpage_image] =>[orig_patent_app_number] => 09813659
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/813659 | Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell | Mar 20, 2001 | Issued |
Array
(
[id] => 6664162
[patent_doc_number] => 20030203488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Viral vectors and line for gene therapy'
[patent_app_type] => new
[patent_app_number] => 09/810490
[patent_app_country] => US
[patent_app_date] => 2001-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11651
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20030203488.pdf
[firstpage_image] =>[orig_patent_app_number] => 09810490
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/810490 | Viral vectors and line for gene therapy | Mar 18, 2001 | Abandoned |
Array
(
[id] => 7640440
[patent_doc_number] => 06395473
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-28
[patent_title] => 'Adenoviral based promoter assay'
[patent_app_type] => B1
[patent_app_number] => 09/743570
[patent_app_country] => US
[patent_app_date] => 2001-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1927
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/395/06395473.pdf
[firstpage_image] =>[orig_patent_app_number] => 09743570
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/743570 | Adenoviral based promoter assay | Mar 6, 2001 | Issued |
Array
(
[id] => 6080915
[patent_doc_number] => 20020081734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Modified muteins of erythropoietin derived from in vitro or in vivo expression system of microorganism'
[patent_app_type] => new
[patent_app_number] => 09/783721
[patent_app_country] => US
[patent_app_date] => 2001-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4933
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20020081734.pdf
[firstpage_image] =>[orig_patent_app_number] => 09783721
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/783721 | Modified muteins of erythropoietin derived from in vitro or in vivo expression system of microorganism | Feb 13, 2001 | Abandoned |
Array
(
[id] => 1179719
[patent_doc_number] => 06740525
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-05-25
[patent_title] => 'Adenoviral capsid containing chimeric protein IX'
[patent_app_type] => B2
[patent_app_number] => 09/780224
[patent_app_country] => US
[patent_app_date] => 2001-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 0
[patent_no_of_words] => 7478
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/740/06740525.pdf
[firstpage_image] =>[orig_patent_app_number] => 09780224
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/780224 | Adenoviral capsid containing chimeric protein IX | Feb 8, 2001 | Issued |
| 09/743394 | METHOD FOR OPTIMIZING THE PRODUCTION OF ADENIOVIRUS VECTORS | Feb 6, 2001 | Abandoned |
Array
(
[id] => 941193
[patent_doc_number] => 06969583
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-29
[patent_title] => 'Method for detecting variant HBV'
[patent_app_type] => utility
[patent_app_number] => 09/781891
[patent_app_country] => US
[patent_app_date] => 2001-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 60
[patent_no_of_words] => 14873
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/969/06969583.pdf
[firstpage_image] =>[orig_patent_app_number] => 09781891
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/781891 | Method for detecting variant HBV | Feb 1, 2001 | Issued |
Array
(
[id] => 6015882
[patent_doc_number] => 20020102655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Methods and constructs for expression of foreign proteins in photosynthetic organisms'
[patent_app_type] => new
[patent_app_number] => 09/775345
[patent_app_country] => US
[patent_app_date] => 2001-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10077
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20020102655.pdf
[firstpage_image] =>[orig_patent_app_number] => 09775345
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/775345 | Methods and constructs for expression of foreign proteins in photosynthetic organisms | Jan 31, 2001 | Issued |
Array
(
[id] => 7134825
[patent_doc_number] => 20040043468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Synthetic internal ribosome entry sites and methods of identifying same'
[patent_app_type] => new
[patent_app_number] => 10/182327
[patent_app_country] => US
[patent_app_date] => 2002-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 31303
[patent_no_of_claims] => 114
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20040043468.pdf
[firstpage_image] =>[orig_patent_app_number] => 10182327
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/182327 | Synthetic internal ribosome entry sites and methods of identifying same | Jan 25, 2001 | Issued |
Array
(
[id] => 6593742
[patent_doc_number] => 20020042097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-11
[patent_title] => 'Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues'
[patent_app_type] => new
[patent_app_number] => 09/767515
[patent_app_country] => US
[patent_app_date] => 2001-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 20949
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20020042097.pdf
[firstpage_image] =>[orig_patent_app_number] => 09767515
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/767515 | Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues | Jan 22, 2001 | Issued |
Array
(
[id] => 1130143
[patent_doc_number] => 06787359
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-07
[patent_title] => 'Gene transfer methods'
[patent_app_type] => B1
[patent_app_number] => 09/743354
[patent_app_country] => US
[patent_app_date] => 2001-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15527
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/787/06787359.pdf
[firstpage_image] =>[orig_patent_app_number] => 09743354
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/743354 | Gene transfer methods | Jan 8, 2001 | Issued |
Array
(
[id] => 1245864
[patent_doc_number] => 06677302
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-13
[patent_title] => 'Compositions and methods for the treatment of viral disorders'
[patent_app_type] => B2
[patent_app_number] => 09/756489
[patent_app_country] => US
[patent_app_date] => 2001-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 24
[patent_no_of_words] => 18849
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/677/06677302.pdf
[firstpage_image] =>[orig_patent_app_number] => 09756489
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/756489 | Compositions and methods for the treatment of viral disorders | Jan 7, 2001 | Issued |
Array
(
[id] => 6889362
[patent_doc_number] => 20010024817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-09-27
[patent_title] => 'Viral nucleotide sequences'
[patent_app_type] => new
[patent_app_number] => 09/745810
[patent_app_country] => US
[patent_app_date] => 2000-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 67
[patent_no_of_words] => 7814
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20010024817.pdf
[firstpage_image] =>[orig_patent_app_number] => 09745810
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/745810 | Viral nucleotide sequences | Dec 25, 2000 | Issued |
Array
(
[id] => 6893989
[patent_doc_number] => 20010016355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-23
[patent_title] => 'AAV capsid vehicles for molecular transfer'
[patent_app_type] => new
[patent_app_number] => 09/746246
[patent_app_country] => US
[patent_app_date] => 2000-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8310
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20010016355.pdf
[firstpage_image] =>[orig_patent_app_number] => 09746246
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/746246 | AAV capsid vehicles for molecular transfer | Dec 21, 2000 | Abandoned |
Array
(
[id] => 7645793
[patent_doc_number] => 06472176
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-10-29
[patent_title] => 'Polynucleotide encoding chimeric protein and related vector, cell, and method of expression thereof'
[patent_app_type] => B2
[patent_app_number] => 09/736743
[patent_app_country] => US
[patent_app_date] => 2000-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8406
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/472/06472176.pdf
[firstpage_image] =>[orig_patent_app_number] => 09736743
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/736743 | Polynucleotide encoding chimeric protein and related vector, cell, and method of expression thereof | Dec 13, 2000 | Issued |